1. Home
  2. AVXL vs AVNW Comparison

AVXL vs AVNW Comparison

Compare AVXL & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$2.52

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

Logo Aviat Networks Inc.

AVNW

Aviat Networks Inc.

HOLD

Current Price

$21.67

Market Cap

278.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVXL
AVNW
Founded
2004
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
237.2M
278.2M
IPO Year
2013
2007

Fundamental Metrics

Financial Performance
Metric
AVXL
AVNW
Price
$2.52
$21.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$22.00
$34.50
AVG Volume (30 Days)
1.3M
149.6K
Earning Date
05-08-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.29
Revenue
N/A
$243,858,000.00
Revenue This Year
N/A
$5.59
Revenue Next Year
N/A
$7.03
P/E Ratio
N/A
$74.14
Revenue Growth
N/A
0.56
52 Week Low
$2.41
$13.92
52 Week High
$13.99
$27.02

Technical Indicators

Market Signals
Indicator
AVXL
AVNW
Relative Strength Index (RSI) 42.55 59.71
Support Level $2.41 $20.76
Resistance Level $2.80 $22.95
Average True Range (ATR) 0.16 1.09
MACD 0.02 0.00
Stochastic Oscillator 26.67 59.27

Price Performance

Historical Comparison
AVXL
AVNW

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About AVNW Aviat Networks Inc.

Aviat Networks Inc provides wireless transport and access networking solutions designed to support telecommunications operators and private network providers situated in various countries. The company offers a range of microwave and millimeter wave radios, network management tools, and services that enable high-capacity, secure, and reliable data transport over wireless networks. Its products serve diverse clients including mobile operators, public safety organizations, utilities, government agencies, and enterprise customers. Aviat generates revenue from the sale of its networking equipment, professional services, and ongoing support contracts. Its operations cover various regions including the Americas, Europe, Asia Pacific, the Middle East, and Africa.

Share on Social Networks: